IS6358A - Farnasýl transferasa latar - Google Patents

Farnasýl transferasa latar

Info

Publication number
IS6358A
IS6358A IS6358A IS6358A IS6358A IS 6358 A IS6358 A IS 6358A IS 6358 A IS6358 A IS 6358A IS 6358 A IS6358 A IS 6358A IS 6358 A IS6358 A IS 6358A
Authority
IS
Iceland
Prior art keywords
transferase inhibitors
farnesyl transferase
farnesyl
inhibitors
transferase
Prior art date
Application number
IS6358A
Other languages
English (en)
Inventor
Michael Wardleworth James
Thomas Boyle Francis
Matusiak Zbigniew
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IS6358A publication Critical patent/IS6358A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS6358A 1999-12-22 2002-04-23 Farnasýl transferasa latar IS6358A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9930318.2A GB9930318D0 (en) 1999-12-22 1999-12-22 Novel compounds
PCT/GB2000/004856 WO2001046137A1 (en) 1999-12-22 2000-12-18 Farnesyl transferase inhibitors

Publications (1)

Publication Number Publication Date
IS6358A true IS6358A (is) 2002-04-23

Family

ID=10866834

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6358A IS6358A (is) 1999-12-22 2002-04-23 Farnasýl transferasa latar

Country Status (27)

Country Link
US (1) US7101897B2 (is)
EP (1) EP1255733B1 (is)
JP (1) JP3742593B2 (is)
KR (1) KR20020063251A (is)
CN (2) CN1680313A (is)
AR (1) AR029460A1 (is)
AT (1) ATE316074T1 (is)
AU (1) AU776003B2 (is)
BR (1) BR0016669A (is)
CA (1) CA2387579A1 (is)
CO (1) CO5360641A1 (is)
CZ (1) CZ20022125A3 (is)
DE (1) DE60025650D1 (is)
EE (1) EE200200206A (is)
GB (1) GB9930318D0 (is)
HU (1) HUP0204135A3 (is)
IL (1) IL149871A0 (is)
IS (1) IS6358A (is)
MX (1) MXPA02005981A (is)
MY (1) MY133606A (is)
NO (1) NO20022924L (is)
NZ (1) NZ518341A (is)
PL (1) PL355887A1 (is)
RU (1) RU2259997C2 (is)
SK (1) SK8642002A3 (is)
WO (1) WO2001046137A1 (is)
ZA (1) ZA200202694B (is)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005117864A1 (en) * 2004-05-28 2005-12-15 Astrazeneca Ab Combination product comprising anastrozole and a dual prenyl transferase inhibitor
WO2006038719A1 (ja) * 2004-10-08 2006-04-13 Kotobuki Pharmaceutical Co., Ltd. ホスホン酸誘導体及び血中の高リン酸が関与する疾患の治療剤
WO2007092285A2 (en) * 2006-02-02 2007-08-16 Link Medicine Corporation Treatment of synucleinopathies
US8232402B2 (en) 2008-03-12 2012-07-31 Link Medicine Corporation Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
AU2009313927A1 (en) 2008-11-13 2010-05-20 Astrazeneca Ab Azaquinolinone derivatives and uses thereof
JP2012520884A (ja) 2009-03-18 2012-09-10 ザ ボード オブ トラスティーズ オブ ザ リランド スタンフォード ジュニア ユニバーシティー フラビウイルス科ウイルス感染症を治療する方法および組成物
WO2011088126A2 (en) * 2010-01-13 2011-07-21 Eiger Biopharmaceuticals, Inc. Treatment of viral infection with prenyltransferase inhibitors

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283906C (en) 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
JPS60233076A (ja) 1984-05-03 1985-11-19 Sumitomo Chem Co Ltd 新規なβ−ラクタム化合物およびその製造法
CA1281720C (en) 1984-11-08 1991-03-19 Makoto Sunagawa Carbapenem compounds and production thereof
KR880006244A (ko) 1986-11-24 1988-07-22 후지사와 도모 기찌 로 3-피롤리디닐티오-1-아자바이스클로[3.2.0]햅트2-엔-2-카르복실산 화합물 및 이의 제조방법
GB8921635D0 (en) 1989-09-25 1989-11-08 Fujisawa Pharmaceutical Co 3-pyrrolidinylthio-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid derivatives
CA2036163C (en) 1990-02-14 2001-06-19 Makoto Sunagawa Novel beta-lactam compounds and their production
AU646012B2 (en) 1990-02-23 1994-02-03 Sankyo Company Limited Carbapenem derivatives having antibiotic activity, their preparation and their use
GB9107363D0 (en) 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
US6083917A (en) 1990-04-18 2000-07-04 Board Of Regents, The University Of Texas System Methods and compositions for the identification, characterization and inhibition of farnesyltransferase
US5185248A (en) * 1990-05-08 1993-02-09 E. R. Squibb & Sons, Inc. Farnesyl-protein transferase assay for identifying compounds that block neoplastic transformation
JPH0578360A (ja) 1991-01-31 1993-03-30 Banyu Pharmaceut Co Ltd ２−［２−（スルフアモイルアルキル）ピロリジニルチオカルバペネム誘導体
GB9107342D0 (en) 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
GB9107341D0 (en) 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
NO302475B1 (no) 1991-06-04 1998-03-09 Sankyo Co 1-metylkarbapenemderivater og farmasöytisk preparat inneholdende disse
JPH04368386A (ja) 1991-06-18 1992-12-21 Sankyo Co Ltd １−メチルカルバペネム−３−カルボン酸の製造法
US5360798A (en) 1991-07-04 1994-11-01 Shionogi Seiyaku Kabushiki Kaisha Aminooxypyrrolidinylthiocarbapenem compounds
CA2080172A1 (en) 1991-10-11 1993-04-12 Scott A. Biller Method for blocking neoplastic transformation of cells induced by ras oncogenes
JPH05239058A (ja) 1991-12-17 1993-09-17 Fujisawa Pharmaceut Co Ltd ３−ピロリジニルチオ−１−アザビシクロ［３．２．０ヘプト−２−エン−２−カルボン酸化合物
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
CZ290002B6 (cs) 1992-03-11 2002-05-15 Sankyo Company Limited Antimikrobiální karbapenemové deriváty, způsob výroby a farmaceutický prostředek
GB9304156D0 (en) 1992-03-26 1993-04-21 Zeneca Ltd Antibiotic compounds
CA2091309A1 (en) 1992-03-26 1993-09-27 Frederic H. Jung Antibiotic compounds
US5608056A (en) 1992-04-13 1997-03-04 Fujisawa Pharmaceutical Co., Ltd. Substituted 3-pyrrolidinylthio-carbapenems as antimicrobial agents
EP0581501B1 (en) 1992-07-21 1998-09-09 Zeneca Limited Antibiotic carbapenem compounds
EP0581502B1 (en) 1992-07-21 1998-10-21 Zeneca Limited Antibiotic carbapenem compounds
CA2099818A1 (en) 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
EP0590885B1 (en) 1992-09-28 2000-03-15 Zeneca Limited Antibiotic carbapenem compounds
CA2106330A1 (en) 1992-10-07 1994-04-08 Patrice J. Siret Antibiotic compounds
CA2118985A1 (en) 1993-04-02 1994-10-03 Dinesh V. Patel Heterocyclic inhibitors of farnesyl protein transferase
CA2165176A1 (en) 1993-06-18 1995-01-05 Samuel L. Graham Inhibitors of farnesyl-protein transferase
JP2534823B2 (ja) 1993-07-07 1996-09-18 日本電気株式会社 印刷装置
US5468733A (en) 1993-09-30 1995-11-21 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
EP0725650A4 (en) 1993-09-30 1999-02-03 Merck & Co Inc FARNESYL-PROTEIN TRANSFERASE INHIBITORS
CA2155448A1 (en) 1994-08-11 1996-02-12 Katerina Leftheris Inhibitors of farnesyl protein transferase
US5571835A (en) 1994-09-29 1996-11-05 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
EP0817630A4 (en) 1995-03-29 1999-01-27 Merck & Co Inc INHIBITORS OF FARNESYL PROTEIN TRANSFERASE
KR100429950B1 (ko) 1995-07-31 2004-06-16 시오노기세이야쿠가부시키가이샤 포스포리파제에이2저해활성을갖는피롤리딘유도체
GB9515975D0 (en) * 1995-08-04 1995-10-04 Zeneca Ltd Chemical compounds
JPH1050029A (ja) 1996-05-28 1998-02-20 Nobuyuki Higuchi 情報記憶装置
WO1998007692A1 (en) 1996-08-17 1998-02-26 Zeneca Limited 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors
JP2001509156A (ja) * 1997-01-29 2001-07-10 ゼネカ・リミテッド ファルネシルプロテイントランスフェラーゼの阻害剤
AR015649A1 (es) 1997-05-07 2001-05-16 Univ Pittsburgh Inhibidores de isoprenil-transferasas proteicas, composiciones que los comprenden y el uso de los mismos para la fabricacion de un medicamento
AU2435199A (en) * 1998-02-10 1999-08-30 Astrazeneca Uk Limited Farnesyl transferase inhibitors

Also Published As

Publication number Publication date
GB9930318D0 (en) 2000-02-09
NZ518341A (en) 2004-01-30
AU776003B2 (en) 2004-08-19
KR20020063251A (ko) 2002-08-01
SK8642002A3 (en) 2002-12-03
JP3742593B2 (ja) 2006-02-08
MY133606A (en) 2007-11-30
CA2387579A1 (en) 2001-06-28
WO2001046137A1 (en) 2001-06-28
HUP0204135A3 (en) 2005-03-29
HUP0204135A2 (hu) 2003-03-28
BR0016669A (pt) 2002-10-08
CN1411442A (zh) 2003-04-16
JP2003518091A (ja) 2003-06-03
AU2201301A (en) 2001-07-03
RU2002119405A (ru) 2004-01-10
MXPA02005981A (es) 2005-07-01
CN1680313A (zh) 2005-10-12
EE200200206A (et) 2003-04-15
US7101897B2 (en) 2006-09-05
CZ20022125A3 (cs) 2002-09-11
EP1255733A1 (en) 2002-11-13
ZA200202694B (en) 2003-12-31
AR029460A1 (es) 2003-07-02
EP1255733B1 (en) 2006-01-18
US20030083348A1 (en) 2003-05-01
RU2259997C2 (ru) 2005-09-10
NO20022924D0 (no) 2002-06-18
ATE316074T1 (de) 2006-02-15
CO5360641A1 (es) 2004-01-30
PL355887A1 (en) 2004-05-31
CN1229344C (zh) 2005-11-30
IL149871A0 (en) 2002-11-10
NO20022924L (no) 2002-06-18
DE60025650D1 (de) 2006-04-06

Similar Documents

Publication Publication Date Title
PT1226136E (pt) Inibidores da tirosina quinase
PT1181017E (pt) Inibidores de metaloproteases
NO996571L (no) Inhibitorer for farnesyl-protein-transferase
NO963860D0 (no) Isoprenyl-transferase-inhibitorer
NO20021239L (no) Pteridinoner som kinase-inhibitorer
PT1224195E (pt) C-aril-glicosidos inibidores de tgls2
PT1194404E (pt) Inibidores de aspartil-protease
NO20012960D0 (no) Farnesylproteintransferase-inhibitorer
DK1272488T3 (da) Tri-aryl-substitueret ethan-PDE4-inhibitorer
DK1339695T3 (da) Farnesyltransferase-inhibitorer
ATE252547T1 (de) Matrixmetalloproteinaseinhibitoren
IS6358A (is) Farnasýl transferasa latar
NO20012961D0 (no) Trisykliske farnesylproteintransferase-inhibitorer
DE60009260D1 (de) Thiopyranderivate as mmp-inhibitoren
ATE214367T1 (de) Farnesyl transferase inhibitoren
AU3514302A (en) 0ovel farnesyl protein transferase inhibitors
DK1087981T3 (da) Prenyltransferaseinhibitorer
NO20015827L (no) Neuronal död inhibitorer
NO20022923L (no) Inhibitorer av farnesyl-protein-transferase
IDP000027420A (id) Inhibitor-inhibitor kinase pirolotriazin